Literature DB >> 30429569

How dogs are teaching researchers new tricks for treating cancer.

Sarah DeWeerdt.   

Abstract

Entities:  

Keywords:  Cancer; Drug discovery; Medical research; Therapeutics

Mesh：

Substances：

Year:  2018        PMID： 30429569     DOI： 10.1038/d41586-018-07365-2

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.

Authors:  Jenna H Burton; Christina Mazcko; Amy LeBlanc; Joseph M Covey; Jiuping Ji; Robert J Kinders; Ralph E Parchment; Chand Khanna; Melissa Paoloni; Sue Lana; Kristen Weishaar; Cheryl London; William Kisseberth; Erika Krick; David Vail; Michael Childress; Jeffrey N Bryan; Lisa Barber; E J Ehrhart; Michael Kent; Timothy Fan; Kelvin Kow; Nicole Northup; Heather Wilson-Robles; Joseph Tomaszewski; Julianne L Holleran; Miguel Muzzio; Julie Eiseman; Jan H Beumer; James H Doroshow; Yves Pommier
Journal:  Clin Cancer Res       Date:  2018-07-30       Impact factor: 12.531

2.  Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.

Authors:  Kevin R Bushell; Yukyoung Kim; Fong Chun Chan; Susana Ben-Neriah; Andrew Jenks; Miguel Alcaide; Daniel Fornika; Bruno M Grande; Sarah Arthur; Randy D Gascoyne; Christian Steidl; Ryan D Morin
Journal:  Blood       Date:  2014-12-02       Impact factor: 22.113

3.  Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma.

Authors:  Laura Marconato; Patrick Frayssinet; Nicole Rouquet; Stefano Comazzi; Vito Ferdinando Leone; Paola Laganga; Federica Rossi; Massimo Vignoli; Lorenzo Pezzoli; Luca Aresu
Journal:  Clin Cancer Res       Date:  2013-12-03       Impact factor: 12.531

4.  Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma.

Authors:  Heather L Gardner; Sarah B Rippy; Misty D Bear; Kim L Cronin; Heather Heeb; Holly Burr; Claire M Cannon; Kumar V Penmetsa; Srikant Viswanadha; Swaroop Vakkalanka; Cheryl A London
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240
  4 in total
  3 in total

1.  Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas.

Authors:  Taismara K Garnica; Jéssika C C Lesbon; Ana C F C M Ávila; Arina L Rochetti; Oscar R S Matiz; Roana C S Ribeiro; Aline Zoppa; Adriana T Nishiya; Mirela T Costa; Andrigo B de Nardi; David J Argyle; Ricardo F Strefezzi; Juliano C Silveira; Heidge Fukumasu
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

2.  Identification of common predisposing loci to hematopoietic cancers in four dog breeds.

Authors:  Benoît Hédan; Édouard Cadieu; Maud Rimbault; Amaury Vaysse; Caroline Dufaure de Citres; Patrick Devauchelle; Nadine Botherel; Jérôme Abadie; Pascale Quignon; Thomas Derrien; Catherine André
Journal:  PLoS Genet       Date:  2021-04-01       Impact factor: 5.917

3.  BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells.

Authors:  Weibo Kong; Sina Sender; Leila Taher; Simon Villa-Perez; Yixuan Ma; Anett Sekora; Barbara C Ruetgen; Bertram Brenig; Julia Beck; Ekkehard Schuetz; Christian Junghanss; Ingo Nolte; Hugo Murua Escobar
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.